Almac

Almac have extensive experience in biomarker discovery both through our commercial partnerships and our internal R&D.

The solutions we offer include:

• Study design
• Advice and Project Management on best approach
• Full laboratory facilities including:

         -Pre-clinical cell line modelling
         -Gene expression including diagnostic proprietary discovery arrays
         -SNP and qPCR analysis, IHC
         -Data analysis for identification of relevant pathways and candidate genelist

Almac have the infrastructure and expertise to enable biomarker discovery in a range of disease areas. Our discovery can begin as early as the pre-clinical phase or can be carried out using retrospective analysis of FFPE datasets or in prospective clinical trials.

For further information click here to contact us.